Regeneron Pharmaceuticals, Inc.
REGNFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Regeneron Pharmaceuticals, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 18 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated May 4, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Vanguard Personalized Indexing Management, LLC | 2026-03-31 | 12,633 | $9.76M | SEC filing |
| CAPITAL INTERNATIONAL LTD /CA/ | 2026-03-31 | 13,610 | $10.5M | SEC filing |
| LOOMIS SAYLES & CO L P | 2026-03-31 | 1,912,310 | $1.48B | SEC filing |
| PINEBRIDGE INVESTMENTS LLC | 2026-03-31 | 13,307 | $10.3M | SEC filing |
| FACTORY MUTUAL INSURANCE CO | 2026-03-31 | 25,600 | $19.8M | SEC filing |
| EVERPAR ADVISORS LLC | 2026-03-31 | 543 | $420K | SEC filing |
| Lansforsakringar Fondforvaltning AB (publ) | 2026-03-31 | 33,101 | $25.6M | SEC filing |
| Moran Wealth Management, LLC | 2026-03-31 | 4,398 | $3.4M | SEC filing |
| TCW GROUP INC | 2026-03-31 | 1,665 | $1.29M | SEC filing |
| Western Wealth Management, LLC | 2026-03-31 | 33 | $25.6K | SEC filing |
| NISSAY ASSET MANAGEMENT CORP /JAPAN | 2026-03-31 | 28,869 | $22.3M | SEC filing |
| Alpine Fox Capital LLC | 2026-03-31 | 1,000 | $773K | SEC filing |
| Caldwell Trust Co | 2026-03-31 | 28 | $21.6K | SEC filing |
| SYM FINANCIAL Corp | 2026-03-31 | 595 | $460K | SEC filing |
| Korea Investment CORP | 2026-03-31 | 73,063 | $56.5M | SEC filing |
| Arnhold LLC | 2026-03-31 | 6,228 | $4.81M | SEC filing |
| LEUTHOLD GROUP, LLC | 2026-03-31 | 9,780 | $7.56M | SEC filing |
| Point72 Asset Management, L.P. | 2026-03-31 | 2,175 | $1.68M | SEC filing |
| DIMENSIONAL FUND ADVISORS LP | 2026-03-31 | 513,060 | $396M | SEC filing |
| Groupe la Francaise | 2026-03-31 | 442 | $303K | SEC filing |
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Regeneron Pharmaceuticals, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-02-09 · Pitofsky Jason: Larger than 101 of the 112 other insider sales of Common Stock on file. SEC filing
- 2026-02-09 · Pitofsky Jason: Larger than 104 of the 112 other insider sales of Common Stock on file. SEC filing
- 2026-02-09 · Pitofsky Jason: Larger than 103 of the 112 other insider sales of Common Stock on file. SEC filing
- 2026-01-07 · Bassler Bonnie L: Larger than 110 of the 112 other insider sales of Common Stock on file. SEC filing
- 2025-11-20 · Bassler Bonnie L: Larger than 107 of the 112 other insider sales of Common Stock on file. SEC filing
- 2025-11-07 · Pitofsky Jason: Larger than 102 of the 112 other insider sales of Common Stock on file. SEC filing
- 2025-10-29 · POON CHRISTINE A: Larger than 105 of the 112 other insider sales of Common Stock on file. SEC filing
- 2025-10-29 · POON CHRISTINE A: Larger than 111 of the 112 other insider sales of Common Stock on file. SEC filing
- 2025-10-29 · POON CHRISTINE A: Larger than all 112 other insider sales of Common Stock on file. SEC filing
- 2025-10-29 · POON CHRISTINE A: Larger than 106 of the 112 other insider sales of Common Stock on file. SEC filing
- 2024-11-01 · McCourt Marion: Larger than 108 of the 112 other insider sales of Common Stock on file. SEC filing
- 2024-10-01 · McCourt Marion: Larger than 108 of the 112 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-05-01 | RYAN ARTHUR F · Director | Common Stock | S — Open market or private sale | −6 | 709.45 | SEC filing |
| 2026-05-01 | RYAN ARTHUR F · Director | Common Stock | S — Open market or private sale | −5 | 711.49 | SEC filing |
| 2026-05-01 | RYAN ARTHUR F · Director | Common Stock | S — Open market or private sale | −14 | 705.56 | SEC filing |
| 2026-05-01 | RYAN ARTHUR F · Director | Common Stock | S — Open market or private sale | −24 | 703.46 | SEC filing |
| 2026-05-01 | RYAN ARTHUR F · Director | Common Stock | S — Open market or private sale | −5 | 701.76 | SEC filing |
| 2026-05-01 | RYAN ARTHUR F · Director | Common Stock | S — Open market or private sale | −2 | 710.87 | SEC filing |
| 2026-05-01 | RYAN ARTHUR F · Director | Common Stock | S — Open market or private sale | −15 | 702.46 | SEC filing |
| 2026-05-01 | RYAN ARTHUR F · Director | Common Stock | S — Open market or private sale | −4 | 707.40 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-02-19 | Zoghbi Huda Y · Director | Non-Qualified Stock Option (right to buy) | M — Exercise or conversion of derivative security | −1,638 | SEC filing |
| 2026-02-19 | Zoghbi Huda Y · Director | Common Stock | M — Exercise or conversion of derivative security | +1,638 | SEC filing |
| 2026-02-09 | Pitofsky Jason · SVP Controller | Non-Qualified Stock Option (right to buy) | M — Exercise or conversion of derivative security | −1,000 | SEC filing |
| 2026-02-09 | Pitofsky Jason · SVP Controller | Common Stock | M — Exercise or conversion of derivative security | +1,000 | SEC filing |
| 2026-01-07 | Bassler Bonnie L · Director | Common Stock | M — Exercise or conversion of derivative security | +1,500 | SEC filing |
| 2026-01-07 | Bassler Bonnie L · Director | Non-Qualified Stock Option (right to buy) | M — Exercise or conversion of derivative security | −1,500 | SEC filing |
| 2026-01-02 | SING GEORGE L · Director | Common Stock | A — Grant, award, or other acquisition | +155 | SEC filing |
| 2026-01-02 | COLES N ANTHONY · Director | Common Stock | A — Grant, award, or other acquisition | +155 | SEC filing |
Showing 8 of 34 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2024-12-20 | POON CHRISTINE A · Director | Common Stock | W — Acquisition or disposition by will or laws of descent | +14 | SEC filing |
Showing 1 of 1 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.